Searched for
AUGMENTIN SALES
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...- Obesity bet may drive focus on chronic segment: Alkem LabsAlkem Labs anticipates its upcoming semaglutide launch will drive a strategic shift from acute treatments to chronic care, including diabet...
- Obesity drug Mounjaro becomes India's top-selling drug by value in OctoberEli Lilly's Mounjaro drug has become India's top seller for October as sales reached one billion rupees. This anti-obesity medication helps...
- GSK's antibiotic drug Augmentin is India's highest-selling brand with Rs 80 crore monthly saleEnhertu, a cancer drug by AstraZeneca, was the top-selling new drug in 2024 with sales of nearly Rs 58 crore. Over 3,100 new brands were la...
- Pharma market picks up pace, sees 10% value growth in NovIndia's pharmaceutical market rebounded in November with 9.9% value growth and 3.1% volume growth. Key therapy areas like cardiac, gastroin...
- Domestic pharmaceutical retail market grows 11 per cent in JulyThe domestic pharmaceutical retail market saw an impressive 11% growth in July, attributed to increased sales of anti-infectives and pain r...
- GSK gets restraining order against Elder LaboratoriesGSK approached the high court against Elder Laboratories early this year for alleged infringement of trademark, including usage of identica...
- Indian pharma market grows over 9 per cent in DecemberAmong the top therapies, cardiac, anti-infectives and neuro/central nervous system have shown a relatively stronger volume growth last mont...
- GSK's Augmentin is India's no.1 drug brandResearch firm PharmaTrac data shows Augmentin sales at Rs 801 crore from November 2022-23. For the month of November, Augmentin sales stood...
- Covid & flu: Sales of respiratory, anti-infective drugs shoot up"We have seen a sharp rise in the sales of drugs like paracetamol, analgesics and drugs for respiratory illnesses," said Rajiv Singhal, gen...
- Surge in viral infections pushes up pharma salesThe volumes were tepid in January, but with flu, Covid-19 and other viral infections spreading fast, February and March saw spikes in volum...
- Indian pharma market grew 12.1% in August, AWACS reportThe wholesale price index (WPI) inflation linked price hike allowed by the government has helped the pharma industry to increase by 10% on ...
- Indian pharma market grew 14.1% in July, AIOCD reportThe fastest growing categories are respiratory which grew at 22.3%, gynaecology - 24%, chemotherapy - 28.4%, urology - 22.5%, ophthalmic - ...
- GSK Pharma Q3 results: Net profit jumps over two-folds to Rs 204 crThe company had reported a net profit of Rs 76.47 crore in the same period of the previous fiscal.
- Reduce GSK Pharma, target Rs 2483: NomuraHowever, the market expects strong revival in EBITDA margins and the stock is factoring in possible delisting if parent Glaxo Plc buys back...
- Anti-diabetic drug tops India's pharma salesIn a grim reminder of the rise of lifestyle diseases, anti-diabetic molecule has for the first time become the largest-selling formulation ...
- Drug companies, distributors slugfest over marginsDrugmakers from GlaxoSmithKline to Lupin are grappling with distributors, whose demand for maintaining commissions threatens to erode profi...
- American firm Abbott consolidates top position in Indian drug marketAmerican firm Abbott Laboratories consolidated its top position in the Indian drug retail market by growing at a faster than its closest co...
- Dr Reddy’s buys GSK’s oral penicillin facility in USDr Reddy’s Laboratories, one of the country’s biggest drug firms, has bought GlaxoSmithKline’s oral penicillin facility and products in the...
- Ranbaxy gets US nod to mkt its drugGurgaon-based pharmaceutical major Ranbaxy Labs today announced that RLL has received approval from the US Food and Drug Administration to ...
Load More
